SEC Contract Filing

Filing Date: 2023-10-10

Document Content:
<DOCUMENT>
<TYPE>EX-10.1
<SEQUENCE>2
<FILENAME>a202310038kex101.htm
<DESCRIPTION>EX-10.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="ifa12ac3fce604c2680e55724aa49fed5_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Exhibit 10.1</font></div></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">Andrew D. Sklawer</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#91;***&#93;</font></div><div style="text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#91;***&#93;</font></div><div><font><br></font></div><div><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">September 18, 2023</font></div><div><font><br></font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Re&#58; Separation and Release Agreement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">Dear Mr. Sklawer&#58;</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;This letter sets forth the substance of the Separation and Release Agreement (the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Agreement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#8221;) that Fresh Tracks Therapeutics, Inc., f&#47;k&#47;a Brickell Biotech, Inc., the parent of Brickell Sub (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Brickell Parent</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#8221;) and Brickell Subsidiary, Inc., d&#47;b&#47;a Brickell Biotech, Inc. (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Brickell Sub</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#8221;), both being Delaware companies with a principal business address located at Founder Central, 2000 Central Avenue, 100, Boulder, Colorado 80301 (Brickell Sub and, together with Brickell Parent and any predecessors of Brickell Sub or Brickell Parent, collectively referred to herein as the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Company</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#8221;) is offering to aid you in your employment transition as a result of the Company&#8217;s decision to downsize its business operations. Except as expressly referenced herein, this Agreement supersedes and replaces all prior understandings and agreements, whether oral or written, regarding the terms and conditions of your employment with the Company, including but not limited to that certain Employment Agreement between you and the Company dated February 21, 2023, and attached hereto as Exhibit A (&#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Employment Agreement</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#8221;) and the Retention Bonus Agreement referenced in Section 3 below. Together, you and the Company may be referred to collectively as the &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Parties</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#8221; and the term &#8220;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Party</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#8221; may refer either to you or Company individually as the circumstances dictate.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;Now therefore, for good and valuable consideration, receipt of which is hereby agreed and acknowledged, and fully intending to be legally bound hereby, the Parties to this Agreement agree as follows&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:36pt"><font style="color:#000000;font-family:'Helvetica',sans-serif;font-size:12pt;font-weight:400;line-height:100%">1.</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%;padding-left:26pt">Separation Date. </font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:400;line-height:100%">Your last day of Company employment will be October 2, 2023 (the &#34;</font><font style="color:#000000;font-family:'Calibri',sans-serif;font-size:13.5pt;font-weight:700;line-height:100%">Separation Date</font><font style="color:#000000;fo